BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan QA, Pediaditakis P, Malakhau Y, Esmaeilniakooshkghazi A, Ashkavand Z, Sereda V, Krupenko NI, Krupenko SA. CHIP E3 ligase mediates proteasomal degradation of the proliferation regulatory protein ALDH1L1 during the transition of NIH3T3 fibroblasts from G0/G1 to S-phase. PLoS One 2018;13:e0199699. [PMID: 29979702 DOI: 10.1371/journal.pone.0199699] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Fekry B, Jeffries KA, Esmaeilniakooshkghazi A, Szulc ZM, Knagge KJ, Kirchner DR, Horita DA, Krupenko SA, Krupenko NI. C16-ceramide is a natural regulatory ligand of p53 in cellular stress response. Nat Commun 2018;9:4149. [PMID: 30297838 DOI: 10.1038/s41467-018-06650-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
2 Tsybovsky Y, Sereda V, Golczak M, Krupenko NI, Krupenko SA. Structure of putative tumor suppressor ALDH1L1. Commun Biol 2022;5:3. [PMID: 35013550 DOI: 10.1038/s42003-021-02963-9] [Reference Citation Analysis]
3 Gao J, Hao Y, Piao X, Gu X. Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention. Int J Mol Sci 2022;23:2682. [PMID: 35269824 DOI: 10.3390/ijms23052682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Krupenko NI, Sharma J, Fogle HM, Pediaditakis P, Strickland KC, Du X, Helke KL, Sumner S, Krupenko SA. Knockout of Putative Tumor Suppressor Aldh1l1 in Mice Reprograms Metabolism to Accelerate Growth of Tumors in a Diethylnitrosamine (DEN) Model of Liver Carcinogenesis. Cancers (Basel) 2021;13:3219. [PMID: 34203215 DOI: 10.3390/cancers13133219] [Reference Citation Analysis]
5 Requena-Jimenez A, Nabiuni M, Miyan JA. Profound changes in cerebrospinal fluid proteome and metabolic profile are associated with congenital hydrocephalus. J Cereb Blood Flow Metab 2021;41:3400-14. [PMID: 34415213 DOI: 10.1177/0271678X211039612] [Reference Citation Analysis]
6 Guzzo MB, Li Q, Nguyen HV, Boom WH, Nguyen L. The Pup-Proteasome System Protects Mycobacteria from Antimicrobial Antifolates. Antimicrob Agents Chemother 2021;65:e01967-20. [PMID: 33468462 DOI: 10.1128/AAC.01967-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Krupenko NI, Sharma J, Pediaditakis P, Helke KL, Hall MS, Du X, Sumner S, Krupenko SA. Aldh1l2 knockout mouse metabolomics links the loss of the mitochondrial folate enzyme to deregulation of a lipid metabolism observed in rare human disorder. Hum Genomics 2020;14:41. [PMID: 33168096 DOI: 10.1186/s40246-020-00291-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Liu X, Li H, Wang S, Zhang J, Liu D. Sesquiterpene lactones of Aucklandia lappa: Pharmacology, pharmacokinetics, toxicity, and structure–activity relationship. Chinese Herbal Medicines 2021;13:167-76. [DOI: 10.1016/j.chmed.2020.11.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Krupenko SA, Krupenko NI. Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression. Chem Biol Interact 2019;302:149-55. [PMID: 30794800 DOI: 10.1016/j.cbi.2019.02.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
10 Krupenko NI, Sharma J, Pediaditakis P, Fekry B, Helke KL, Du X, Sumner S, Krupenko SA. Cytosolic 10-formyltetrahydrofolate dehydrogenase regulates glycine metabolism in mouse liver. Sci Rep 2019;9:14937. [PMID: 31624291 DOI: 10.1038/s41598-019-51397-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Krupenko SA, Horita DA. The Role of Single-Nucleotide Polymorphisms in the Function of Candidate Tumor Suppressor ALDH1L1. Front Genet 2019;10:1013. [PMID: 31737034 DOI: 10.3389/fgene.2019.01013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chao C, Lai C, Badrealam KF, Lo J, Shen C, Chen C, Chen R, Viswanadha VP, Kuo W, Huang C. CHIP attenuates lipopolysaccharide‐induced cardiac hypertrophy and apoptosis by promoting NFATc3 proteasomal degradation. J Cell Physiol 2019;234:20128-38. [DOI: 10.1002/jcp.28614] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]